CL2013001914A1 - Metodo para determinar el potencial miopico de un paciente; metodo para diagnosticar la susceptibilidad de un paciente a un trastorno relacionado con la longitud ocular; metodo para tratar un trastorno relacionado con la longitud ocular; y kit. - Google Patents
Metodo para determinar el potencial miopico de un paciente; metodo para diagnosticar la susceptibilidad de un paciente a un trastorno relacionado con la longitud ocular; metodo para tratar un trastorno relacionado con la longitud ocular; y kit.Info
- Publication number
- CL2013001914A1 CL2013001914A1 CL2013001914A CL2013001914A CL2013001914A1 CL 2013001914 A1 CL2013001914 A1 CL 2013001914A1 CL 2013001914 A CL2013001914 A CL 2013001914A CL 2013001914 A CL2013001914 A CL 2013001914A CL 2013001914 A1 CL2013001914 A1 CL 2013001914A1
- Authority
- CL
- Chile
- Prior art keywords
- patient
- disorder related
- eye length
- diagnose
- susceptibility
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/398—Electrooculography [EOG], e.g. detecting nystagmus; Electroretinography [ERG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
- G02C2202/24—Myopia progression prevention
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161432984P | 2011-01-14 | 2011-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013001914A1 true CL2013001914A1 (es) | 2014-03-07 |
Family
ID=45562446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013001914A CL2013001914A1 (es) | 2011-01-14 | 2013-06-28 | Metodo para determinar el potencial miopico de un paciente; metodo para diagnosticar la susceptibilidad de un paciente a un trastorno relacionado con la longitud ocular; metodo para tratar un trastorno relacionado con la longitud ocular; y kit. |
Country Status (17)
Country | Link |
---|---|
US (3) | US8951729B2 (es) |
EP (1) | EP2663653B1 (es) |
JP (2) | JP6141193B2 (es) |
KR (1) | KR102011947B1 (es) |
CN (2) | CN103314116B (es) |
AR (1) | AR084866A1 (es) |
AU (1) | AU2012205439B2 (es) |
BR (1) | BR112013017745B1 (es) |
CA (1) | CA2819250C (es) |
CL (1) | CL2013001914A1 (es) |
CO (1) | CO6731117A2 (es) |
ES (1) | ES2676393T3 (es) |
MX (1) | MX355606B (es) |
RU (1) | RU2013137831A (es) |
TW (1) | TWI631334B (es) |
WO (1) | WO2012097213A2 (es) |
ZA (1) | ZA201304334B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3552587A1 (en) | 2008-12-22 | 2019-10-16 | Medical College of Wisconsin, Inc. | Method and apparatus for limiting growth of eye length |
RU2013137831A (ru) * | 2011-01-14 | 2015-02-20 | Юниверсити Оф Вашингтон Тру Итс Сентер Фор Коммершлайзейшн | Способы диагностирования и лечения связанных с длиной глаза нарушений |
EP3261525B1 (en) * | 2015-02-27 | 2021-09-29 | University Of Washington | Methods and reagents for predicting predisposition to refractive error |
CA3011794A1 (en) | 2016-01-18 | 2017-07-27 | Waveshift Llc | Evaluating and reducing myopiagenic effects of electronic displays |
US10912456B2 (en) | 2016-01-27 | 2021-02-09 | Johnson & Johnson Vision Care, Inc. | Ametropia treatment tracking methods and system |
US10042181B2 (en) * | 2016-01-27 | 2018-08-07 | Johnson & Johnson Vision Care, Inc. | Ametropia treatment tracking methods and system |
TW202244570A (zh) | 2016-08-01 | 2022-11-16 | 華盛頓大學 | 用於治療近視的眼用鏡片 |
JP6637217B2 (ja) * | 2017-03-06 | 2020-01-29 | 株式会社坪田ラボ | 近視予防又は抑制剤、マウス近視誘導モデルの作製方法、及び、近視予防又は抑制医薬スクリーニング方法 |
IL258706A (en) * | 2017-04-25 | 2018-06-28 | Johnson & Johnson Vision Care | Treatment follow-up methods in emmetropia and system |
CN110914743B (zh) | 2017-05-08 | 2021-08-13 | 视窗视觉公司 | 用于降低近视的接触镜片及用于制造该接触镜片的方法 |
EP3495875A1 (en) * | 2017-12-06 | 2019-06-12 | Essilor International | Method and system for selecting a color filter, optical article comprising such a color filter |
US10884264B2 (en) | 2018-01-30 | 2021-01-05 | Sightglass Vision, Inc. | Ophthalmic lenses with light scattering for treating myopia |
WO2020083382A1 (en) * | 2018-10-26 | 2020-04-30 | Ai Technologies Inc. | Accurate prediction and treatment of myopic progression by artificial intelligence |
JP7097845B2 (ja) * | 2019-04-23 | 2022-07-08 | ジェネシスヘルスケア株式会社 | 近視のリスクを判定する方法 |
KR102396522B1 (ko) | 2020-07-28 | 2022-05-10 | 가톨릭대학교 산학협력단 | 안저 후극부의 기하학적 구조를 이용한 병적 근시 판별 방법 및 시스템 |
EP4006626A1 (en) | 2020-11-26 | 2022-06-01 | Carl Zeiss Vision International GmbH | Spectacle lens design, spectacle lens kit and method of manufacturing a spectacle lens |
AU2022330019A1 (en) * | 2021-08-20 | 2024-03-07 | The Johns Hopkins University | Photoreceptor cells for retinal and macular repair |
WO2023114149A1 (en) * | 2021-12-13 | 2023-06-22 | Welch Allyn, Inc. | Measurements of keratometry and axial length |
WO2023140064A1 (ja) * | 2022-01-24 | 2023-07-27 | 株式会社ニデック | 眼科情報処理装置及び眼科情報処理プログラム |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
US5837461A (en) * | 1996-10-31 | 1998-11-17 | Mcw Research Foundation | Detection of cone-photoreceptor-based vision disorders |
US6706867B1 (en) * | 2000-12-19 | 2004-03-16 | The United States Of America As Represented By The Department Of Health And Human Services | DNA array sequence selection |
EP1256632A3 (en) * | 2001-05-07 | 2004-01-02 | Smithkline Beecham Corporation | High throughput polymorphism screening |
US20040110179A1 (en) * | 2002-03-15 | 2004-06-10 | Shuber Anthony P. | Method for alteration detection |
US20050208555A1 (en) * | 2004-03-16 | 2005-09-22 | Affymetrix, Inc. | Methods of genotyping |
US7906289B2 (en) * | 2008-07-28 | 2011-03-15 | Kaohsiung Medical University | Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia |
EP3552587A1 (en) * | 2008-12-22 | 2019-10-16 | Medical College of Wisconsin, Inc. | Method and apparatus for limiting growth of eye length |
RU2013137831A (ru) * | 2011-01-14 | 2015-02-20 | Юниверсити Оф Вашингтон Тру Итс Сентер Фор Коммершлайзейшн | Способы диагностирования и лечения связанных с длиной глаза нарушений |
-
2012
- 2012-01-13 RU RU2013137831/10A patent/RU2013137831A/ru not_active Application Discontinuation
- 2012-01-13 AU AU2012205439A patent/AU2012205439B2/en active Active
- 2012-01-13 TW TW101101512A patent/TWI631334B/zh active
- 2012-01-13 JP JP2013549558A patent/JP6141193B2/ja active Active
- 2012-01-13 CN CN201280004629.2A patent/CN103314116B/zh active Active
- 2012-01-13 EP EP12702348.9A patent/EP2663653B1/en active Active
- 2012-01-13 KR KR1020137021311A patent/KR102011947B1/ko active IP Right Grant
- 2012-01-13 US US13/349,877 patent/US8951729B2/en active Active
- 2012-01-13 CN CN201710205364.7A patent/CN106987628B/zh active Active
- 2012-01-13 ES ES12702348.9T patent/ES2676393T3/es active Active
- 2012-01-13 MX MX2013006056A patent/MX355606B/es active IP Right Grant
- 2012-01-13 CA CA2819250A patent/CA2819250C/en active Active
- 2012-01-13 BR BR112013017745-4A patent/BR112013017745B1/pt active IP Right Grant
- 2012-01-13 WO PCT/US2012/021185 patent/WO2012097213A2/en active Application Filing
- 2012-01-16 AR ARP120100143 patent/AR084866A1/es not_active Application Discontinuation
-
2013
- 2013-06-12 ZA ZA2013/04334A patent/ZA201304334B/en unknown
- 2013-06-28 CL CL2013001914A patent/CL2013001914A1/es unknown
- 2013-07-15 CO CO13167565A patent/CO6731117A2/es unknown
-
2014
- 2014-12-23 US US14/581,116 patent/US20150111782A1/en not_active Abandoned
-
2017
- 2017-02-27 JP JP2017034948A patent/JP6545738B2/ja active Active
- 2017-06-23 US US15/631,542 patent/US10487361B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2013001914A1 (es) | Metodo para determinar el potencial miopico de un paciente; metodo para diagnosticar la susceptibilidad de un paciente a un trastorno relacionado con la longitud ocular; metodo para tratar un trastorno relacionado con la longitud ocular; y kit. | |
BR112012032948A2 (pt) | dispositivos injectores e método de suprimento de solução oftálmica à córnea do olho | |
IL259775B (en) | Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease | |
CL2015000061A1 (es) | Anticuerpos biespecíficos anti-vegf/anti-ang-2 y su utilización en el tratamiento de enfermedades vasculares oculares | |
BR112012020050A2 (pt) | acessório ocular iluminado | |
BR112013022493A2 (pt) | equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão | |
BR112013022927A2 (pt) | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição | |
BR112013024169A2 (pt) | método para o tratamento e prevenção da doença de parkinson | |
BRPI0916627A2 (pt) | projeto de lente e método para impedir ou retardar a progressão de miopia | |
HK1201438A1 (en) | Treatment of ocular disease | |
SG11201601286SA (en) | Spectacles and method for determining the centre of the pupil of both of the wearer's eyes | |
ZA201502600B (en) | Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular huntington's disease | |
HRP20130830T1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
DK2747763T3 (da) | (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser | |
BR112015007758A2 (pt) | dispositivo para um tratamento médico de uma esclera, método para tratar a esclera em um sujeito e método para tratar uma alteração patológica ou doença do olho. | |
EP3628326C0 (en) | METHODS AND SUBSTANCES FOR TREATING PUMP DISEASE | |
ES2606627T8 (es) | Anticuerpos específicos anti-CD160 para el tratamiento de trastornos oculares basados en la neoangiogénesis | |
HK1186660A1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica | |
IL260078B (en) | Therapy used to treat Gaucher disease | |
CL2015000537A1 (es) | Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos. | |
EP2707486A4 (en) | DIAGNOSIS AND TREATMENT OF FRIEDREICH ATAXIA | |
EP3013425A4 (en) | Treatment and diagnosis of ocular disease | |
FR2993564B1 (fr) | Derives d'imidazopyridine utiles dans le traitement du diabete | |
EP2734221A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER DISEASE BY ADMINISTRATION OF AN ANGIOGENIC MEDIUM |